The
small GTPases of the Ras and Rho families are widely involved in
tumorigenesis and
metastasis. We recently showed that
YM529/ONO-5920, a new developed
bisphosphonate, inhibits the
mevalonate pathway, is required for the prenylation of the
small GTPases. In this study, we investigated whether
YM529/ONO-5920 inhibits
tumor cell migration, invasion, adhesion, and
metastasis in B16BL6 cells, a mouse
melanoma cell line. It was found that
YM529/ONO-5920 significantly inhibited lung
metastasis, cell migration, invasion, and adhesion at concentrations that did not show anti-proliferative effects on B16BL6 cells.
YM529/ONO-5920 also inhibited the expression of
matrix metalloproteinases (
MMPs) and very late
antigens (VLAs). Furthermore,
YM529/ONO-5920 suppressed Rho activation, but not activation of Ras. The results indicate that
YM529/ONO-5920 suppresses the Rho/ROCK pathways, thereby inhibiting B16BL6 cell migration, invasion, adhesion and
metastasis. These findings suggest that
YM529/ONO-5920 has potential clinical applications for the treatment of tumour cell
metastasis.